EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions

Tushar Madaan, Kyla Doan, Alexandra Hartman iD, Dominick Gherardini, Alec Ventrola, Yuhang Zhang, Nalinikanth Kotagiri iD

Experimental Dermatology · 2024-12 · 33 (12)

DOI: 10.1111/exd.70019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Dermatology, online erschienen am 06.12.2024. Verfasst von Tushar Madaan und 6 weiteren Autor:innen. Beteiligte Einrichtung: James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Microbiota, Skin Diseases, Skin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Congressionally Directed Medical Research Programs, NCI NIH HHS, Office of Extramural Research, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human skin hosts an estimated 1000 bacterial species that are essential for maintaining skin health. Extensive clinical and preclinical studies have established the significant role of the skin microbiome in dermatological disorders such as atopic dermatitis, psoriasis, diabetic foot ulcers, hidradenitis suppurativa and skin cancers. In these conditions, the skin microbiome is not only altered but, in some cases, implicated in disease pathophysiology. Microbiome‐based therapies (MBTs) represent an emerging category of live biotherapeutic products with tremendous potential as a novel intervention platform for skin diseases. Beyond using established wild‐type strains native to the skin, these therapies can be enhanced to express targeted therapeutic molecules, offering more tailored treatment approaches. This review explores the role of the skin microbiome in various common skin disorders, with a particular focus on the development and therapeutic potential of MBTs for treating these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaSkin DiseasesSkinHumansDermatitis, AtopicPsoriasisHidradenitis SuppurativaSkin NeoplasmsProbioticsDiabetic Foot

Stichwörter der Autor:innen

acne vulgarisatopic dermatitisdiabetic foot diseasehidradenitis suppurativamicrobiome‐based therapeuticspsoriasisskin cancerskin microbiome

Autor:innen und Institutionen

  • James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: Alexandra Hartman, Nalinikanth Kotagiri

Förderung

  • Congressionally Directed Medical Research Programs
  • NCI NIH HHS
  • Office of Extramural Research, National Institutes of Health
  • NHLBI NIH HHS
  • Office of Extramural Research

Zitieren

APA

Madaan, T., Doan, K., Hartman, A., Gherardini, D., Ventrola, A., Zhang, Y., & Kotagiri, N. (2024). Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions. Experimental Dermatology, 33(12). https://doi.org/10.1111/exd.70019

Vancouver

Madaan T, Doan K, Hartman A, Gherardini D, Ventrola A, Zhang Y, et al. Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions. Experimental Dermatology. 2024;33(12). doi:10.1111/exd.70019

BibTeX
@article{Madaan2024,
  author = {Madaan, Tushar and Doan, Kyla and Hartman, Alexandra and Gherardini, Dominick and Ventrola, Alec and Zhang, Yuhang and Kotagiri, Nalinikanth},
  title = {Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions},
  journal = {Experimental Dermatology},
  year = {2024},
  volume = {33},
  number = {12},
  doi = {10.1111/exd.70019}
}
Kostenlos starten →